Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK.
Department of Respiratory Medicine, University College London, London, UK.
Respir Res. 2024 Jan 18;25(1):33. doi: 10.1186/s12931-023-02589-x.
No single pulmonary function test captures the functional effect of emphysema in idiopathic pulmonary fibrosis (IPF). Without experienced radiologists, other methods are needed to determine emphysema extent. Here, we report the development and validation of a formula to predict emphysema extent in patients with IPF and emphysema.
The development cohort included 76 patients with combined IPF and emphysema at the Royal Brompton Hospital, London, United Kingdom. The formula was derived using stepwise regression to generate the weighted combination of pulmonary function data that fitted best with emphysema extent on high-resolution computed tomography. Test cohorts included patients from two clinical trials (n = 455 [n = 174 with emphysema]; NCT00047645, NCT00075998) and a real-world cohort from the Royal Brompton Hospital (n = 191 [n = 110 with emphysema]). The formula is only applicable for patients with IPF and concomitant emphysema and accordingly was not used to detect the presence or absence of emphysema.
The formula was: predicted emphysema extent = 12.67 + (0.92 x percent predicted forced vital capacity) - (0.65 x percent predicted forced expiratory volume in 1 second) - (0.52 x percent predicted carbon monoxide diffusing capacity). A significant relationship between the formula and observed emphysema extent was found in both cohorts (R = 0.25, P < 0.0001; R = 0.47, P < 0.0001, respectively). In both, the formula better predicted observed emphysema extent versus individual pulmonary function tests. A 15% emphysema extent threshold, calculated using the formula, identified a significant difference in absolute changes from baseline in forced vital capacity at Week 48 in patients with baseline-predicted emphysema extent < 15% versus ≥ 15% (P = 0.0105).
The formula, designed for use in patients with IPF and emphysema, demonstrated enhanced ability to predict emphysema extent versus individual pulmonary function tests.
NCT00047645; NCT00075998.
在特发性肺纤维化(IPF)中,没有单一的肺功能测试能够捕捉肺气肿的功能影响。在没有经验丰富的放射科医生的情况下,需要其他方法来确定肺气肿的程度。在这里,我们报告了一种预测 IPF 合并肺气肿患者肺气肿程度的公式的开发和验证。
该开发队列包括来自英国伦敦皇家布朗普顿医院的 76 名合并 IPF 和肺气肿的患者。该公式通过逐步回归生成,将肺功能数据的加权组合拟合到高分辨率计算机断层扫描上的肺气肿程度。测试队列包括两项临床试验的患者(n=455[n=174 例肺气肿];NCT00047645,NCT00075998)和来自皇家布朗普顿医院的真实世界队列的患者(n=191[n=110 例肺气肿])。该公式仅适用于患有 IPF 和合并肺气肿的患者,因此不适用于检测肺气肿的存在与否。
该公式为:预测肺气肿程度=12.67+(0.92×预计用力肺活量百分比)-(0.65×预计 1 秒用力呼气量百分比)-(0.52×预计一氧化碳弥散量百分比)。在两个队列中都发现了公式与观察到的肺气肿程度之间的显著关系(R=0.25,P<0.0001;R=0.47,P<0.0001)。在这两个队列中,该公式均优于个体肺功能测试预测观察到的肺气肿程度。使用该公式计算的 15%的肺气肿程度阈值,在预测基线后 48 周的用力肺活量时,在基线预测的肺气肿程度<15%与≥15%的患者之间,能够显著区分绝对值的变化(P=0.0105)。
该公式专为 IPF 和肺气肿患者设计,与个体肺功能测试相比,预测肺气肿程度的能力得到了增强。
NCT00047645;NCT00075998。